Form 8-K - Current report:
SEC Accession No. 0001829126-25-003349
Filing Date
2025-05-05
Accepted
2025-05-05 06:03:32
Documents
17
Period of Report
2025-05-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nexalintec_8-k.htm   iXBRL 8-K 32298
2 EXHIBIT 5.1 nexalintec_ex5-1.htm EX-5.1 10245
3 EXHIBIT 10.1 nexalintec_ex10-1.htm EX-10.1 17214
4 GRAPHIC image_001.jpg GRAPHIC 2753
  Complete submission text file 0001829126-25-003349.txt   291726

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE nxl-20250505.xsd EX-101.SCH 3750
6 XBRL DEFINITION FILE nxl-20250505_def.xml EX-101.DEF 26614
7 XBRL LABEL FILE nxl-20250505_lab.xml EX-101.LAB 36724
8 XBRL PRESENTATION FILE nxl-20250505_pre.xml EX-101.PRE 25238
19 EXTRACTED XBRL INSTANCE DOCUMENT nexalintec_8-k_htm.xml XML 5832
Mailing Address 1776 YORKTOWN SUITE 550 HOUSTON TX 77056
Business Address 1776 YORKTOWN SUITE 550 HOUSTON TX 77056 (832) 260-0222
Nexalin Technology, Inc. (Filer) CIK: 0001527352 (see all company filings)

EIN.: 275566468 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41507 | Film No.: 25910759
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)